PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 77 filers reported holding PROQR THRAPEUTICS N V in Q4 2021. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $124,469 | -19.8% | 95,745 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $155,107 | -23.9% | 95,745 | 0.0% | 0.00% | -25.0% |
| Q1 2023 | $203,937 | -39.0% | 95,745 | +6.0% | 0.00% | -50.0% |
| Q4 2022 | $334,055 | +119.8% | 90,285 | +396.3% | 0.01% | +100.0% |
| Q3 2021 | $152,000 | -41.3% | 18,191 | -52.6% | 0.00% | -50.0% |
| Q2 2021 | $259,000 | -27.5% | 38,408 | +6.5% | 0.01% | -74.2% |
| Q4 2019 | $357,000 | – | 36,051 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |